Known systemic risk factors are vascular comorbidities such as hypertension, diabetes, dyslipidemia, and nocturnal hypotension, as well as obstructive sleep apnea, smoking and vasoactive medications, but the mechanistic evidence remains incomplete (Evans et al
From retatrutide 8 mg, start at 5 mg
The Interaction Between GLP-1s and Oral Contraceptives Some versions of GLP-1s may impact the efficacy of oral contraceptives
The future of obesity treatment UT Southwestern plans to open a state-of-the-art interdisciplinary obesity management center at Texas Health Dallas, where patients can see obesity medicine specialists, bariatric surgeons, and plastic surgeons in a single location
Medication may not be appropriate for everyone